Literature DB >> 31637507

Is Preoperative Fibrinogen Associated with the Survival Prognosis of Gastric Cancer Patients? A Multi-centered, Propensity Score-Matched Retrospective Study.

Lin-Yong Zhao1, Yong-Liang Zhao2, Jun-Jiang Wang3, Qi-Di Zhao4, Wen-Qi Yi4, Qing Yuan4, Xin-Zu Chen1, Yong Li3, Kun Yang1, Xiao-Long Chen1, Wei-Han Zhang1, Kai Liu1, Hua-Yang Pang1, Danil Galiullin1,5, Hui Wang1, Li-Fei Sun1, Xiao-Hai Song1, Jia-Bin Zheng3, Xue-Qing Yao3, Zong-Guang Zhou1, Pei-Wu Yu6, Jian-Kun Hu7.   

Abstract

BACKGROUND: The prognostic significance of preoperative plasma fibrinogen in patients with operable gastric cancer remains under debate. This study aimed to elucidate the prognostic value of fibrinogen in gastric cancer patients underwent gastrectomy.
METHODS: A total of 4351 patients with gastric cancer collected from three comprehensive medical centers were retrospectively evaluated. Patients were categorized by minimum P value using X-tile, while the baseline confounders for fibrinogen was balanced through propensity score matching (PSM). The relationships between fibrinogen and other clinicopathologic features were evaluated, and nomogram was constructed to assess its prognostic improvement compared with TNM staging system.
RESULTS: Fibrinogen was significantly correlated with macroscopic type, tumor differentiation, tumor size, and T and N stage. The factors, fibrinogen and T stage as well as N stage, were identified to be independent prognostic factors after PSM. Nomogram based on fibrinogen demonstrated a smaller Akaike information criterion (AIC) and a larger concordance index (C-index) than TNM staging system, illustrating that fibrinogen might be able to improve the prognostic accuracy.
CONCLUSIONS: Preoperative plasma fibrinogen levels in gastric cancer patients were significantly correlated with tumor progression, which could be regarded as a reliable marker for survival prognostic prediction.

Entities:  

Year:  2019        PMID: 31637507     DOI: 10.1007/s00268-019-05191-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  4 in total

1.  Plasma fibrinogen acts as a predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer: a retrospective study of 1004 Chinese breast cancer patients.

Authors:  Yihua Wang; Yu Wang; Rui Chen; Zhenrong Tang; Yang Peng; Yudi Jin; Ailin Lan; Nan Ding; Yuran Dai; Linshan Jiang; Shengchun Liu
Journal:  BMC Cancer       Date:  2021-05-12       Impact factor: 4.430

2.  Impact of Type of Postoperative Complications on Long-Term Survival of Gastric Cancer Patients: Results From a High-Volume Institution in China.

Authors:  Hua-Yang Pang; Lin-Yong Zhao; Hui Wang; Xiao-Long Chen; Kai Liu; Wei-Han Zhang; Kun Yang; Xin-Zu Chen; Jian-Kun Hu
Journal:  Front Oncol       Date:  2021-10-11       Impact factor: 6.244

3.  The Significance of Fibrinogen in Combination with the Neutrophil to Lymphocyte Ratio in Predicting the Prognosis of Patients with Gastric Cancer.

Authors:  Xinran Li; Jiamin Zheng; Min Yan; Ye Lu; Xiangtao Pan
Journal:  Cancer Manag Res       Date:  2022-08-04       Impact factor: 3.602

4.  Sintilimab, a PD-1 Inhibitor, Completely Reversed Rarely Refractory Hypofibrinogenemia in a Gastric Cancer Patient: A Case Report and Review of the Literature.

Authors:  Shuzhen Ma; Qi Dang; Yali Yang; Yongliang Liu; Yuping Sun; Meili Sun
Journal:  Front Oncol       Date:  2020-10-19       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.